The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected compound annual growth rate (CAGR) of 8.6% from 2024 to 2034. By the end of 2034, the market ecosystem is anticipated to expand substantially, reaching an …